HomeAI · summaries
Storia in 3 fonti
Draig bags another $65M to speed testing of brain drugs
The cash will support mid-stage trials of a prospect the company claims to have “best-in-disease” potential treating major depressive disorder.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Draig bags another $65M to speed testing of brain drugs
The cash will support mid-stage trials of a prospect the company claims to have “best-in-disease” potential treating major depressive disorder.
- ·
morningstar.com
Draig Therapeutics Closes Oversubscribed $65 Million Series B to Accelerate Development of Highly Specific AMPA and GABAA Receptor…
Draig Therapeutics Closes Oversubscribed $65 Million Series B to Accelerate Development of Highly Specific AMPA and GABAA Receptor Modulators in Neuropsychiatric Disorders
